April 12, 2007 - Suros Surgical Systems, Inc. a subsidiary of women's imaging group, Hologic, Inc.announced today the commercial launch of the Suros Celero,the first U.S. FDA-cleared spring loaded, vacuum assisted core biopsy device for the breast ultrasound market.
With the option of firing inside or outside the breast, the device is designed to access hard-to-reach lesions in the axilla, near the chest wall, near implants or behind the nipple. The lightweight design of the handheld Celero and its echogenic needle reportedly provide smooth penetration to lesions while reducing deflection and offer a clearly visible aperture location for target verification under ultrasound imaging prior to tissue acquisition. Celero securely holds the tissue sample in place while acquiring large cores. The philosophy behind firing and collecting tissue in two separate steps is that it allows for confirmation.
Related Content
News | Breast Biopsy Systems
July 7, 2021 — GE Healthcare announced the installation of Serena Bright in five hospitals and radiology centers around ...
July 07, 2021 
News | Breast Imaging
January 4, 2021 — Hologic, Inc. announced it has completed the acquisition of SOMATEX Medical Technologies GmbH, a ...
January 04, 2021 
News | Prostate Cancer
According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their lifetime. It’s both the second most common cancer and second most common cause of cancer death in American men. Early detection is critical and can increase a man’s chances of survival.
August 20, 2019 News | Biopsy Systems
Dune Medical Devices has just completed the first in-man cases for Smart Biopsy, its percutaneous soft tissue biopsy device which leverages the real-time tissue characterization capability of its radiofrequency (RF) spectroscopy technology.
March 29, 2019 
Technology | Interventional Radiology
The U.S. Food and Drug Administration (FDA) cleared the Ion endoluminal system from Intuitive Surgical Inc. to enable minimally invasive biopsy in the peripheral lung.
February 20, 2019 
News | Prostate Cancer
Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound platform, as the two companies work to improve the way prostate cancer is visualized and detected. Cambridge Consultants is applying deep learning to high-resolution micro-ultrasound imaging to identify potential suspicious regions of tissue and inform urologists who may want to consider this additional data in their biopsy protocol. Early results show real promise, according to the companies.
February 12, 2019 
News | Breast Biopsy Systems
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce unnecessary breast biopsies, according to a new study appearing in the journal Radiology
January 17, 2019 
Videos | Radiation Oncology
Aadel Chaudhuri, M.D., assistant professor of radiation oncology, Washington University, St. Louis, Mo., explains his ...
November 07, 2018 
News | Radiation Oncology
October 30, 2018 — A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to ...
October 30, 2018 
Technology | Breast Biopsy Systems
Leica Biosystems announced the U.S. launch of MammoPort, the first integrated specimen containment and transport system for breast tissue biopsies.
October 03, 2018 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now